logo for Checkmate Pharmaceuticals

Checkmate Pharmaceuticals

Manufacturing · Massachusetts, United States · 30 Employees

View Company Info for Free

About

Headquarters

245 Main St Fl 2, Cambridge, Massachusetts, 021...

Phone Number

(617) 682-3625

Revenue

$10.1 Million

Stock Symbol

CMPI

Industry

Pharmaceuticals Healthcare

Highlights

$229M

Total Funding Amount

$75M

Most Recent Funding Amount

5

Number of Funding Rounds

Who is Checkmate Pharmaceuticals

Checkmate Pharmaceuticals is a biotechnology company focused on developing its proprietary technology to harness the power of the immune system tocombat cancer.Headquartered out of Massachusetts.Read more

Checkmate Pharmaceuticals's Social MediaPopular SearchesCheckmate PharmaceuticalsCheckmate Pharmaceuticals IncCheckmate Pharmaceuticals Security Corporation IncSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: CMPIShow more

Checkmate Pharmaceuticals Org Chart

Barry Labinger

Chief Executive Officer

PhoneEmail
Evan Walters

Vice President, Cmc

PhoneEmail
Paul Berry

Vice President, Quality

PhoneEmail

PhoneEmail

Similar Companies to Checkmate Pharmaceuticals

See more similar companies

Checkmate Pharmaceuticals Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateAug 07, 2020
RoundStock Issuance/Offering
Amount$75M
Investors
Funding DateJun 10, 2020
RoundSeries C
Amount$85M
InvestorsNovo Holdings, Omega Funds, Sectoral Asset Management, F-Prime Capital, venBio Partners, Decheng Capital, Medixci, Longitude Capital, Sofinnova Investments, Clough Capital Partners, BrightEdge
Funding DateDec 12, 2018
RoundOther Financing Round
Amount$22M
InvestorsF-Prime Capital Partners, Decheng Capital, Sofinnova Ventures, venBio
See More

$229M

Total Funding Amount

$75M

Most Recent Funding Amount

5

Number of Funding Rounds

Acquisitions & Subsidiaries

Aug 15, 2019

Libtayo

Dec 26, 2015

Decibel Therapeutics

May 03, 2015

Checkmate Pharmaceuticals

See More Acquisitions & Subsidiaries

Checkmate Pharmaceuticals Tech Stack

A closer look at the technologies used by Checkmate Pharmaceuticals

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Checkmate Pharmaceuticals News & Media

  • The M&A Class Action Firm Continues the Investigation of Checkmate Pharmaceuticals, Inc. - CMPI

    New York, New York--(Newsfile Corp. - May 16, 2022) - Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Checkmate Pharmaceuticals, Inc. (CMPI), relating to its proposed acquisition by Regeneron Pharmaceuticals, Inc. Under the terms...
  • Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update

    CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced first quarter 2022 financial results and provided a business update. “We remain focused on the execution of the clinical program for vidutolimod and are delighted with the opportunity to become part of Regeneron, who wi
  • SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Checkmate Pharmaceuticals, Inc. Buyout

    Wilmington, Delaware--(Newsfile Corp. - April 20, 2022) - Rigrodsky Law, P.A. is investigating Checkmate Pharmaceuticals, Inc. ("Checkmate") (NASDAQ: CMPI) regarding possible breaches of fiduciary duties and other violations of law related to Checkmate's agreement to be acquired by Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Under the terms of the agreement, Checkmate's shareholders will receive $10.50 in cash for each share of Checkmate common stock they own.To learn more about this investi
Read more news

Frequently Asked Questions regarding Checkmate Pharmaceuticals

Where is Checkmate Pharmaceuticals located?
Checkmate Pharmaceuticals's headquarters are located at 245 Main St Fl 2, Cambridge, Massachusetts, 02142, United States
What is Checkmate Pharmaceuticals's phone number?
Checkmate Pharmaceuticals's phone number is (617) 682-3625
What is Checkmate Pharmaceuticals's stock symbol?
Checkmate Pharmaceuticals's stock symbol is CMPI
What is Checkmate Pharmaceuticals's official website?
Checkmate Pharmaceuticals's official website is www.checkmatepharma.com
What is Checkmate Pharmaceuticals's Revenue?
Checkmate Pharmaceuticals's revenue is $10.1 Million
What is Checkmate Pharmaceuticals's SIC code?
Checkmate Pharmaceuticals's SIC: 28,283
What is Checkmate Pharmaceuticals's NAICS code?
Checkmate Pharmaceuticals's NAICS: 32,325
How many employees does Checkmate Pharmaceuticals have?
Checkmate Pharmaceuticals has 30 employees
What industry does Checkmate Pharmaceuticals belong to?
Checkmate Pharmaceuticals is in the industry of: Pharmaceuticals, Healthcare
What is Checkmate Pharmaceuticals competition?
Checkmate Pharmaceuticals top competitors include: Precision Biologics, INmune Bio, Annexon Biosciences, Eureka Therapeutics
What companies has Checkmate Pharmaceuticals acquired?
Checkmate Pharmaceuticals has acquired the companies: Libtayo, Decibel Therapeutics, Checkmate Pharmaceuticals
What technology does Checkmate Pharmaceuticals use?
Some of the popular technologies that Checkmate Pharmaceuticals uses are: WordPress.org, Drupal, reCAPTCHA, PHP
Who is the CEO of Checkmate Pharmaceuticals?
Checkmate Pharmaceuticals's CEO is Barry Labinger
How do I contact Checkmate Pharmaceuticals?
Checkmate Pharmaceuticals contact info: Phone number: (617) 682-3625 Website: www.checkmatepharma.com
What does Checkmate Pharmaceuticals do?

Checkmate Pharmaceuticals is a biotechnology company focused on developing its proprietary technology to harness the power of the immune system to combat cancer.Headquartered out of Massachusetts.... Read More

What are Checkmate Pharmaceuticals social media links?
Checkmate Pharmaceuticals Linkedin page Checkmate Pharmaceuticals Twitter page
How much funding has Checkmate Pharmaceuticals raised to date?
Checkmate Pharmaceuticals has raised $229 Million in 5 funding rounds
When was the last funding round for Checkmate Pharmaceuticals?
Checkmate Pharmaceuticals closed its last funding round on Aug 07, 2020 with the amount of $75 Million
Who invested in Checkmate Pharmaceuticals?
Checkmate Pharmaceuticals has 21 investors including Sofinnova Ventures, venBio Partners, VenBio and Sofinnova Ventures.
Is Checkmate Pharmaceuticals a public company?
Yes, Checkmate Pharmaceuticals is a public company and is traded under the symbol CMPI
See more information about Checkmate Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.